Genetic testing for gynecologic cancer

Clinically actionable gynecologic cancer testing for your patients and their family members

 

Start an order

Are you missing patients who need genetic testing?

All patients with ovarian cancer qualify for genetic testing based on clinical guidelines criteria, yet 80% never get tested, an estimated 400,000 women in the US.1

We believe there are far more ovarian cancer patients who should be considered for genetic testing than are currently receiving testing.

We can help streamline the genetic testing process. Start an order today >

Learn more

Benefits of testing

Genetic information impacts clinical management and prevention

Learn more

Test options

Gynecologic cancer panels with clear medical management guidelines

Learn more

Results

Understanding your patients' results and next steps

Learn more

Invitae advantage

Fast, affordable, high-quality genetic testing you can count on

Learn more

Benefits of genetic testing

Genetic testing for gynecologic cancers can help inform treatment and clinical management, as well as aid in the prevention of future cancers for patients who test positive.

Cancer treatment

Some cancers may be more responsive to personalized therapy with targeted agents such as PARP inhibitors or immunotherapy. Genetic information may qualify patients for participation in clinical trials or research studies.

Future diagnoses

Increased surveillance can identify cancer at its earliest, most treatable stage. Risk-reducing surgery and/or chemoprevention can significantly decrease the chance of future cancers in the same or different organ systems.

Family members

Genetic information can benefit close relatives and allow for risk stratification. Relatives at high risk can undergo enhanced surveillance, while those without the family variant may be able to avoid unnecessary procedures.

Although the great majority of patients who select insurance billing already pay less than $100 out of pocket with Invitae, our simple out-of-pocket cost estimator can bring peace of mind.

For patients who do not meet their insurance company's testing criteria, we offer $250 patient-pay pricing.

Test options

Professional society guidelines have recommended genetic testing for all ovarian cancer, fallopian tube cancer, and primary peritoneal cancer patients since 2010.2

Invitae Breast and Gyn Cancers Guidelines-Based Panel

An expert panel of genes associated with a significantly increased lifetime risk of hereditary gynecological cancer. All genes on this panel have published management guidelines.

View panel

Invitae Common Hereditary Cancers Panel

A comprehensive panel designed to maximize diagnostic yield for individuals with a personal or family history of mixed cancers affecting these organ systems.

View panel

View all cancer panels

 

Not sure which panel is right for your patient?

Consult with one of our board-certified genetic counselors, available Monday through Friday, 5 am to 5 pm Pacific, to identify patients who could benefit from testing and differentiate between tests.

Ready to get started? Create an account today.

Create an account

What to do with your patients’ results

positive

Positive result

Refer to our clinical medical management guide for actionable, gene-specific next steps. Download the guide >

Our board-certified genetic counselors are available to answer your questions about test results and even counsel your patients directly. Clinical consult >

Test blood relatives at no additional charge with Invitae’s family variant testing program. Learn more >

positive

Negative result

Expand to a larger hereditary cancer panel if needed within 90 days of receiving results, at no additional charge. View our cancer panels >

Our board-certified genetic counselors are available to answer your questions about test results and even counsel your patients directly. Clinical consult >

Informed families

Enable cancer prevention and early detection for your patient’s family members.

For patients who undergo panel or gene testing and are found to have a clinically actionable variant, their blood relatives can have up to a 50% risk of having the same variant.

Invitae offers family variant testing at no additional charge for all blood relatives of patients who undergo gene or panel testing at Invitae and have a positive result.

Learn more

Invitae advantage

Invitae testing is covered by most insurance plans and we will not hold a sample or report while managing insurance claims.

Our $250 patient-pay option and patient assistance program help make high-quality testing accessible.

Option to expand to a larger hereditary cancer panel if needed within 90 days of receiving results, at no additional charge.

Genetic counselors available on demand to help identify patients who could benefit from testing, discuss tough cases, and even counsel your patients directly.

Get started

1. Request free kits for collecting patient specimens

2. Order a test using Invitae’s HIPAA-compliant online portal or on paper

  • Call Clinical Consult at 800-436-3037 if you would like to review patient cases or differentiate between testing options.

  • Patients can also contact Client Services for billing and insurance-related questions.

3. Receive an email when your results are ready (14 days on average)

  • If you have any questions about the results or their clinical implications, our genetic counselors are available to discuss.

Take the first step by requesting a free specimen collection kit or starting an order today.

Request a kit       Start an order

Tools for your clinic

Invitae’s reference guides offer direction on when to consider genetic testing and provide management guidelines. We have also created patient resources for you to share with your patients when speaking to them about genetic testing.

CancerCHECK

Identify patients who meet typical criteria for insurance coverage

View

Family history questionnaire

Collect your patient's full family history to inform management

View

Management guidelines

Clinically actionable management guidelines for positive results, gene by gene

View

Risks and references poster

Gene by gene risks for cancer, categorized by organ system

View

Use this video to start the conversation about genetic testing with your patients.

Have a question or comment? Let us know.

Our team is here to answer your questions about ordering, billing, policies, and logistics as you are becoming familiar with our services.

Contact us

Subscribe to our mailing list

Stay updated on the latest in gynecologic cancer. We will send you information on relevant topics once or twice a month.

Subscribe

References:

1. Childers CP et al. National estimates of genetic testing in women with a history of breast or ovarian cancer. JCO. 2017;35(34):3800-6.

2. Daly MB et al. Genetic/familial high-risk assessment: Breast and ovarian. J Natl Compr Canc Netw. 2010;8:562-94.

Invitae is committed to delivering high-quality, affordable testing, with the goal of improving patients’ lives while also saving the healthcare system valuable dollars.

Learn more